Munich - Delayed Quote EUR
Diamyd Medical AB (DMN.MU)
0.8910
+0.0620
+(7.48%)
At close: June 4 at 8:18:58 AM GMT+2
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Cash Flow
-156,174
-129,181
-110,962
-93,219
-109,468
Investing Cash Flow
2,427
-27,994
28,401
-76,722
132,533
Financing Cash Flow
119,035
142,284
86,542
142,155
56,724
End Cash Position
102,436
112,758
127,533
119,761
139,376
Capital Expenditure
-4,423
-8,025
-11,442
-34,652
-4,225
Issuance of Capital Stock
105,317
135,208
75,271
150,000
60,000
Free Cash Flow
-160,597
-137,206
-122,404
-127,871
-113,693
8/31/2021 - 10/15/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IVBIY Innovent Biologics Inc.
29.00
+11.07%
KRBPQ Kiromic BioPharma, Inc.
0.0358
-40.83%
RSPI RespireRx Pharmaceuticals Inc.
0.0018
+20.00%
KANT Kineta, Inc.
0.2159
-4.21%
ZIVO ZIVO Bioscience, Inc.
17.51
0.00%
IPHA Innate Pharma S.A.
2.1400
+0.47%
CLYM Climb Bio Inc
1.2900
0.00%
PMN ProMIS Neurosciences, Inc.
0.5037
+2.80%
GRTX Galera Therapeutics, Inc.
0.0236
-8.88%
CALC CalciMedica, Inc.
1.7150
+3.94%